Palumbo Wealth Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Palumbo Wealth Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	66,232 +1,001	+2%	+$2.64K	0.03%	234
2026 Q1	$253K	Buy	65,231 +24,098	+59%	+$59.2K	0.06%	192
2025 Q4	$80.2K	Sell	41,133 -984	-2%	-$1.61K	0.02%	218
2025 Q3	$35.6K	Buy	42,117 +456	+1%	+$335	0.01%	176
2025 Q2	$30.2K	Buy	41,661 +499	+1%	+$375	0.01%	197
2025 Q1	$35.4K	Buy	41,162 +12,687	+45%	+$18.9K	0.01%	185
2024 Q4	$47.8K	Buy	28,475 +8,888	+45%	+$21.3K	0.02%	174
2024 Q3	$55.8K	Buy	19,587 +1,794	+10%	+$4.64K	0.02%	154
2024 Q2	$41.6K	Buy	+17,793	New	+$46.5K	0.02%	148

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Palumbo Wealth Management's NAUT Position: Q2 2026 in Review

Palumbo Wealth Management increased its Nautilus Biotechnolgy (NAUT) stake by 1.5% in Q2 2026, buying an estimated $2.64K and bringing the position to 66,232 shares worth $124K. The position accounts for 0.03% of the portfolio, ranked #234.

Palumbo Wealth Management first reported a position in NAUT in Q2 2024 and has held it in 9 quarters since. The position peaked at $253K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Palumbo Wealth Management held 66,232 shares of Nautilus Biotechnolgy worth $124K as of Q2 2026.
Palumbo Wealth Management bought 1,001 Nautilus Biotechnolgy shares in Q2 2026, an estimated $2.64K.
Nautilus Biotechnolgy made up 0.03% of Palumbo Wealth Management's portfolio in Q2 2026, its #234 holding.
Palumbo Wealth Management first reported a position in Nautilus Biotechnolgy in Q2 2024 and has held it in 9 quarters since.
Palumbo Wealth Management's Nautilus Biotechnolgy position peaked at $253K in Q1 2026.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.